2008 Xcelerated ProfitsReport- Portfolio Update Archive
2008: January | February | March | April | May | June | July | August | September | October | November | December
——————————————————————————–
December 2008
12/31/2008 – Xcelerated Profits Portfolio Update: Lock In 50% Profits On Tesoro
Let’s end 2008 in style by locking in profits on refining company Tesoro (NYSE: TSO). Having entered the position at
12/24/2008 – Looking For An Anti-Smoking New Year’s Resolution?
Conscious that you may have other pressing duties to attend to at this time, we’ll keep this week’s update short and sweet We start with Nabi Biopharmaceuticals (Nasdaq: NABI), which is
12/17/2008 - Xcelerated Profits Report – Portfolio Update
Before we get started today, just a quick note to let you know that the January issue will be winging its way to you at the end of this week. As is customary in the first issue of the New Year, all our experts will bring you an outlook/forecast for 2009. You’ll hear from
12/17/2008 - Immersion Signs New Licensing Deal Here’s How To Play It
In spite of the wilting economy and stock market, one of the few companies with huge potential is Immersion Corp. (Nasdaq: IMMR). If you’re a longtime reader no surprise there
12/10/2008 – Another Milestone And A New CFO For Accuray
First things first – earnings news One of our retail sector plays, Costco (Nasdaq: COST) will report its fiscal first quarter earnings tomorrow – and indications suggest the news will be
12/03/2008 – The Importance Of Diversification And Defense
Well, it’s official: The U.S. economy is in a recession. Has been for a year now. That’s according to a report from the National Bureau of Economic Research on
——————————————————————————–
November 2008
11/26/2008 - The CyberKnife Hits Italy
With the Thanksgiving holiday on tap, we realize you may have places to go and people to see, so we’ll blast through this week’s update as fast as we can
11/20/2008 – XPR BUY Alert
When we made our recommendation to buy the Franklin Templeton Emerging Markets Fund (NYSE: EMF) in the October issue, we advised to buy into the position in three separate
11/19/2008 - Americans In Cost-Cutting Mode And Costco Fits The Bill
While this year’s financial mess has already claimed several major companies and left thousands more struggling to survive, a lucky minority are
11/12/2008 – Medivation Pushes Dimebon Trial Back In Hopes Of Securing Greater Longer-Term Success
We begin this week with big news for Medivation (Nasdaq: MDVN). In addition to reporting its third quarter results
11/05/2008 – Leading Portfolio Manager Sees The Bottom In Sight And Opportunities
“You will probably see a few more declines, but we’re beginning to see the bottom of this and so the opportunities are quite interesting, quite attractive
——————————————————————————–
October2008
10/29/2008 – Two Positions Closed & Take Profits On VMware Puts
Unfortunately, the whipsaw market has claimed another couple of positions in our portfolio. Last Friday, coffee chain Starbucks (Nasdaq: SBUX) closed below our
10/28/2008 - Starbucks Hits Our Stop-Loss Sell Your Position
Just a quick note to let you know that Starbucks (Nasdaq: SBUX) closed below our protective stop-loss last Friday, so if you haven’t already sold your shares, make sure you
10/27/2008 - Starbucks Hits Our Stop-Loss Sell Your Position
Just a quick note to let you know that Starbucks (Nasdaq: SBUX) closed below our protective stop-loss last Friday, so if you haven’t already sold
10/22/2008 – Pfizer Partners With Medivation On Dimebon And Hands Over $225 Million
It’s official: Medivation (Nasdaq: MDVN) and Pfizer (NYSE: PFE) are now clear to co-develop Medivation’s Dimebon drug, which treats both Alzheimer’s and Huntington’s diseases
10/15/2008 – L-1 Still On The Contract Trail: Another $37 Million Set To Hit The Books
Before we kick off today, I’m pleased to announce that this Friday, we’ll be kicking off a brand new feature for you
10/10/2008 – Special Market Alert: Panic! No, Wait Don’t Panic
With the stock market in the midst of yet another disastrous plunge, let me take a moment to empathize with you and say that I share the pain of
10/10/2008 – Sell Alert: Exit Your Position In Akeena Solar
Unfortunately, the market’s continued plunge stopped us out of one of our positions yesterday. We had a 25% stop-loss in place on our stock position in
10/08/2008 – Add To Your Position In The Franklin Templeton Emerging Markets Fund
The rapid decline of the world’s stock markets is certainly giving investors a rough ride. But the silver lining is that it plays into our hands with
10/08/2008 – Central Banks Of The World Unite But Can This “Six-Pack” Actually Ease The Market’s Hangover
No doubt about it there is outright panic in the financial markets right now. Not even an unprecedented, co-ordinated move by the U.S. Federal Reserve, Bank of England, European Central Bank, Bank of Canada, plus
10/06/2008 – Special Market Alert: Prepare For Volatility But Avoid Panic At All Costs
In the wake of the government’s approval for the Wall Street bailout package last Friday, some investors might be tempted to think
10/02/2008 – Sell Alert: Nabi Biopharmaceuticals (Nasdaq: NABI) Hits Trailing-Stop Exit The Position
The market selloff has claimed our position in Nabi Biopharmaceuticals (Nasdaq: NABI). We had a trailing-stop in place at $4.23 – a level that the stock hit
10/01/2008 – Spending Control Could Mean Big Money For Big Pharma
At a time when obtaining credit is more difficult than ever, with banks tightening the screws on would-be lenders, consultancy firm
——————————————————————————–
September2008
09/24/2008 – An Award For Stupidity
I don’t know if you know this, but Wall Street just came up with a new degree. Widely available, this one is given for Stupidity. And for some, it comes with special honors and a prize
09/18/2008 – Sell Alert: Close Out Of Your Citigroup (NYSE: C) Position
In the March issue, we took a position on Citigroup (NYSE: C) and used our deep-in-the-money covered call strategy to buy it with a 50% cushion built in
09/17/2008 – Somanetics’ Reports A Strong Quarter
Let’s get right down to it, because the news these last few days has been distracting to say the least. With everybody focusing on the financials, it’s easy to get caught up in
09/10/2008 – The Gates-Seinfeld Ad Wins Little Acclaim” But Microsoft Keeps On Chugging
You don’t need to be hip to stay in the game? Although Microsoft’s (NASDAQ: MSFT) televised account of how Jerry Seinfeld meets up with Bill Gates in a Shoe Circus store didn’t
09/03/2008 – Medivation Shares Soar To New Highs On Pfizer Deal
Today saw the Xcelerated Profits Report portfolio get a good shot in the arm, courtesy of Medivation
——————————————————————————–
August2008
08/27/2008 – The Next Celgene Yours For The Taking
Last week, medical device maker Accuray (Nasdaq: ARAY) reported its fourth-quarter and full-year financial results. The firm earned 9 cents per share for
08/20/2008 – The Market Falls But L-1 Flies
Even as the broader stock market falls, shares of our defense sector play, L-1 Identity Solutions (NYSE: ID) have soared. The company is doing what it does best
08/13/2008 – Up 16% On Starbucks As Firm Focuses On China
Although its stock is languishing between $8 and $8.50, Accuray (Nasdaq: ARAY) still continues to see super growth in its cutting-edge CyberKnife cancer treatment system
08/06/2008 – A Dramatic Reduction In Cancer Treatment Time
The announcement came just too late to squeeze into our update last week, so we’ll give you the scoop now. And it’s more good news for our defense sector play
08/05/2008 – Sell Alert: Sell Asset Acceptance Corp (Nasdaq: AACC)
Asset Acceptance Capital Corp. (Nasdaq: AACC) just reported quarterly numbers that were less than impressive, considering that
——————————————————————————–
July 2008
07/30/2008 – Starbucks cuts back on another 1000 jobs
This week isn’t over yet. As this current market has proven, there’s rarely a dull moment and just about anything can happen. But in the meantime, here’s where we stand right now
07/23/2008 – Wachovia falters badly but should pick itself back up again
Hold on a minute or two; we’ve got a lot to go over this time around. The numbers are officially in, and now we know
07/18/2008 – Medivation Soars As Mainstream Picks Up The Dimebon Vibes
Stay tuned to your e-mail today, as we’ll be sending you the August newsletter later on. In the meantime, here’s some breaking news on our Medivation
07/16/2008 – Oil Continues Its Dive But Consumer Prices See Largest Jump In 26 Years
The Xcelerated Profits Report portfolio lit up a bright shade of green today, with all our open positions firmly in positive territory. The gains came, following a
07/15/2008 – Gold Enjoying A Hot July Sell Your Gold Bull Spread For A 37% Profit
Checked out the price of gold recently? Since traders returned after the July 4 holiday, the yellow metal has tacked on
07/11/2008 – Starbucks Has Hit Our Entry Price
Just a quick note to let you know that Starbucks (Nasdaq: SBUX), my recommendation in the July issue, traded at our buy order price of
07/09/2008 – From Oil To Wind This Renowned Oilman Embraces The Breeze
My timing couldn’t have been better. After I landed in San Francisco, I called the office of Dr. David Hung, CEO of Medivation (Nasdaq: MDVN). Since I’m out here for several weeks, I wanted to
07/02/2008 – Starbucks Scales Back Its US Operations
It’s the news that Wall Street wanted to hear. News that we told you about in our most recent issue two weeks ago. With a venti latte in his system
——————————————————————————–
June 2008
06/30/2008 – Enzon Hits Our Stop-Loss Exit The Position
We were unfortunately stopped out of our position on Enzon Pharmaceuticals (Nasdaq: ENZN) today. As the markets have sold off, it’s likely that
06/25/2008 – FDA Trouble For Eli-Lilly’s Effient And That’s Good News For Bristol-Myers
Just a few days after recommending Bristol-Myers Squibb (NYSE: BMY) in the July issue, we’ve already received some good news this week when the Food & Drug Administration announced
06/24/2008 – We’re Stopped Out On The Second Half Of BioMarin But Still Bag A 63% Gain
We were stopped out of the second half of our BioMarin (Nasdaq: BMRN) on Monday after the shares suffered
06/19/2008 – Accuray’s Obstacles Are “Fixable”
We currently have more than 20 “open” positions in the Xcelerated Profits Report portfolio. Of those, we have three bona-fide losers, based on our original entry prices and adjusted for
06/11/2008 – Snail Mail Or E-Mail Which Do You Prefer?
You can set your clock by it Whenever Apple (Nasdaq: AAPL) is set to make an announcement about a new generation of i-Phone
06/05/2008 – The Wachovia Waiting Game
You’ve probably seen the news splashed all over the financial news headlines over the last couple of days – and there’s no doubt that as far as our portfolio is concerned
——————————————————————————–
May2008
05/28/2008 – The Microsoft-Yahoo Mating Dance Continues
The dating world can be a tough place. Having already tried to consummate their relationship once – only to abandon the plan just as
05/22/2008 – Powerful Investor Pushes Enzon Board To Sell The Firm
“Explore strategic alternatives.” What a brilliant example of corporate lingo! It’s a great way to say something without actually saying much
05/14/2008 – Banks Hit The 80% Mark And Wachovia Makes A Boardroom Shuffle
Break out your party hat the world’s banks have now disclosed 80% of their projected losses from their doomed subprime-related investments and subsequent ugly debt write downs
05/07/2008 – L-1 Releases First-Quarter Results And Beats Estimates
Today saw two more of our recommended companies release their first-quarter earnings results. We’ll tackle L-1 Identity Solutions (NYSE: ID) first
05/02/2008 - The Lowdown On Immersion’s First Quarter
I believe haptics is at a tipping point, fast becoming an imperative for the ideal intuitive user interface.” So said new Immersion (Nasdaq: IMMR) president and
——————————————————————————–
April 2008
04/25/2008 – Immersion Gets A New Leader
After a harrowing few months for the stock market and for many investors, we finally seem to be moving in the right direction. Don’t get me wrong
04/17/2008 – A Tale Of Two Cities: Breaking Down The Infosys And Wachovia Earnings
I visited last October on an investment research trip – and I’ll be heading back there in February 2009. The reason is simple: India’s economy is surging forward and
04/11/2008 – Citigroup Seeks Its First Infrastructure Fund
Whenever you hear the word “infrastructure,” you know the conversation is about to turn serious. After all, it’s the foundation of a solid economy and is what makes everyday life
04/02/2008 – Bernanke Calls For Recession
How do you warn folks about an economic recession without actually saying the word? You’d think that would take a pretty special talent. Step forward, Ben Bernanke
——————————————————————————–
March2008
03/28/2008 – Quarterly Earnings On Tap Prepare For More Volatility
Since we released the April issue to you this past Monday, we’ve already had two pieces of good news on our latest recommendation
03/20/2008 – The Infamous “Icahn Lift” Is Ready To Boost Enzon Shares
Carl Icahn – one of Wall Street’s most renowned and successful investors – is on another mission. This pitbull is sinking his teeth into one of the companies in our portfolio – and
03/17/2008 – Bear Gets Mauled And The Fed Jumps In
Thanks for ruining my Sunday, Bear. Mammoth financial events just don’t happen on Sundays. Bagel shops are full. Folks ride their bikes. Many take the chance to
03/12/2008 – And The Medical Devices Product Of The Year Is
I couldn’t have put it much better myself When hedge fund giant Blackstone Group (NYSE: BX) held its recent earnings conference call
03/06/2008 – Cash Out On The Remainder Of Your December Natural Gas Spreads
In January last year, we initiated two bullish option positions on December 2008 natural gas futures. Specifically, we’re currently long the
03/05/2008 – Another Strong Quarter For Immersion, While Pfizer Goes
Things continue to progress well at Immersion (Nasdaq: IMMR). Last week, the firm reported another set of solid quarterly results
03/04/2008 – Sell Your March $15 Medivation (Nasdaq: MDVN) Puts, Then Buy September $15 Puts
I want to give you a quick update on Medivation (Nasdaq: MDVN) – and issue new instructions for our put options position
03/04/2008 – SELL ALERT: Mylan Labs (NYSE: MYL) Has Hit Our Stop-Loss Sell Your Shares
Despite its acquisition of Germany’s Merck AG last May and India’s Matrix – additions that give it increased exposure to the European and Asian markets respectively – Mylan Labs (NYSE: MYL) shares have
——————————————————————————–
February2008
02/27/2008 – A Dose Of Healthcare Earnings Data
Today’s news centers on one of the healthcare companies we currently have in the XPR portfolio – BioMarin (Nasdaq: BMRN). The firm just reported quarterly earnings and
02/25/2008 – Take Profits On Half Your December Natural Gas Spreads
In January last year, we initiated two bullish option positions on December 2008 natural gas futures. Specifically, we’re currently long the
02/13/2008 – BioMarin Surges To Highest Level Since 2000, With Profitability Expected This Year
“BioMarin will likely be one of the most attractive growth stories in biotech for the next several years.” Whenever we hear that about one of our recommendations
02/08/2008 – An Overdone Selloff Accuray Begins Long Climb Back Up
When a company misses its quarterly earnings estimates, you can pretty much take it to the bank that the stock is going to get crushed.
——————————————————————————–
January 2008
01/31/2008 – Medivation’s Russian Results Validated Dimebon Set For Phase III Trials
There’s little doubt that Accuray’s (Nasdaq: ARAY) quarterly earnings miss and subsequent share price woe is the main news in our portfolio today. Earlier this morning, Karim sent an e-mail focusing on
01/31/2008 – Accuray Misses Earnings Here’s Our Take
There is at least one certainty about stocks and the stock market: That there are no certainties. After the market closed last night, Accuray (Nasdaq: ARAY), one of our most promising
01/23/2008 - Pfizer’s Results Are InHere Are The Details As We Make A New Play On The Blue Chip Pharma Firm
Hope you’ve had a chance to read the February issue that we sent to you earlier today. Among plenty of other topics, you’ll see that
01/23/2008 – SELL ALERT: Sell Instructions On Cynosure And A 35% Profit Locked In On L-3
When investors get scared, they unfortunately shoot first and ask questions later. That mentality has sent Cynosure (Nasdaq: CYNO) shares lower since
01/11/2008 - The Best Of The Bunch From The JP Morgan Healthcare Conference
Talk about a busy week. Here’s an overview of how it stacked up
01/04/2008 – The Market Tumbles Into 2008 Here’s What We Say
“Collateralized debt obligations.” Those three words are enough to send waves of panic coursing through the stock market these days. In the midst of a full-scale real estate slump
2008 Archives | 2007 Archives | 2006 Archives